Literature DB >> 22886791

Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8⁺ memory T cells in the bone marrow.

Gloria H Y Lin1, Fanny Edele, Achire N Mbanwi, Michael E Wortzman, Laura M Snell, Mariana Vidric, Katrin Roth, Anja E Hauser, Tania H Watts.   

Abstract

The persistence of memory lymphocytes is a critical feature of adaptive immunity. The TNF family ligand 4-1BBL supports the antigen-independent survival of CD8⁺ memory T cells. Here, we show that mice lacking 4-1BB only on αβ T cells show a similar defect in CD8⁺ T-cell recall responses, as previously shown in 4-1BBL-deficient mice. We show that 4-1BB is selectively expressed on BM CD8⁺ but not CD4⁺ memory T cells of unimmunized mice. Its ligand, 4-1BBL, is found on VCAM-1⁺ stromal cells, CD11c⁺ cells, and a Gr1(lo) myeloid population in unimmunized mice. Adoptive transfer of in vitro generated memory T cells into mice lacking 4-1BBL only on radioresistant cells recapitulates the defect in CD8⁺ T-cell survival seen in the complete knockout mice, with smaller effects of 4-1BBL on hematopoietic cells. In BM, adoptively transferred DsRed CD8⁺ memory T cells are most often found in proximity to VCAM-1⁺ cells or Gr1⁺ cells, followed by B220⁺ cells and to a much lesser extent near CD11c⁺ cells. Thus, a VCAM-1⁺CD45(-) stromal cell is a plausible candidate for the radioresistant cell that provides 4-1BBL to CD8⁺ memory T cells in the BM.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886791     DOI: 10.1002/eji.201242503

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  [Stromal cells as coordinators of adaptive immune response and immunological memory].

Authors:  A E Hauser
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

2.  Automated quantification of hematopoietic cell - stromal cell interactions in histological images of undecalcified bone.

Authors:  Sandra Zehentmeier; Zoltan Cseresnyes; Juan Escribano Navarro; Raluca A Niesner; Anja E Hauser
Journal:  J Vis Exp       Date:  2015-04-08       Impact factor: 1.355

3.  Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.

Authors:  Bettina Weigelin; Elixabet Bolaños; Alvaro Teijeira; Ivan Martinez-Forero; Sara Labiano; Arantza Azpilikueta; Aizea Morales-Kastresana; José I Quetglas; Esther Wagena; Alfonso Rodríguez Sánchez-Paulete; Lieping Chen; Peter Friedl; Ignacio Melero
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-01       Impact factor: 11.205

Review 4.  The TNF family in T cell differentiation and function--unanswered questions and future directions.

Authors:  Michael Croft
Journal:  Semin Immunol       Date:  2014-03-06       Impact factor: 11.130

5.  The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137+ FOXP3+ Regulatory CD4 T Cells.

Authors:  Bardees M Foda; Ashley E Ciecko; David V Serreze; William M Ridgway; Aron M Geurts; Yi-Guang Chen
Journal:  J Immunol       Date:  2020-04-15       Impact factor: 5.422

Review 6.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

Review 7.  Bone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T Cells.

Authors:  Francesca Di Rosa; Thomas Gebhardt
Journal:  Front Immunol       Date:  2016-02-16       Impact factor: 7.561

8.  Memory CD8(+) T cells colocalize with IL-7(+) stromal cells in bone marrow and rest in terms of proliferation and transcription.

Authors:  Özen Sercan Alp; Sibel Durlanik; Daniel Schulz; Mairi McGrath; Joachim R Grün; Marcus Bardua; Koichi Ikuta; Evridiki Sgouroudis; René Riedel; Sandra Zehentmeier; Anja E Hauser; Motokazu Tsuneto; Fritz Melchers; Koji Tokoyoda; Hyun-Dong Chang; Andreas Thiel; Andreas Radbruch
Journal:  Eur J Immunol       Date:  2015-02-27       Impact factor: 5.532

9.  Redirection to the bone marrow improves T cell persistence and antitumor functions.

Authors:  Anjum B Khan; Ben Carpenter; Pedro Santos E Sousa; Constandina Pospori; Reema Khorshed; James Griffin; Pedro Velica; Mathias Zech; Sara Ghorashian; Calum Forrest; Sharyn Thomas; Sara Gonzalez Anton; Maryam Ahmadi; Angelika Holler; Barry Flutter; Zaida Ramirez-Ortiz; Terry K Means; Clare L Bennett; Hans Stauss; Emma Morris; Cristina Lo Celso; Ronjon Chakraverty
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.